IV NEWS
Events and training - June 16, 2023
PICC, port or Hickman? Make the right choice in oncology
“I think that the biggest issue in our service is choosing which device for which patients,” said Professor Caren Randon,…
Events and training May 10, 2023
Invisible to invaluable: Honouring International Nurses Day
Worldwide, there are approximately 27 million nurses and midwives, making up nearly 50% of the global healthcare workforce.1 On the…
“Complications of IV catheter therapy are simply the result of one complex and highly variable mechanical system—IV catheter equipment design,...
Scientific publications May 5, 2023
New clinic study: Reduce hazardous drug contamination with BD
Even in small concentrations, hazardous drug exposure can cause adverse effects such as internal organ damage, genetic mutations, increased rates…
News and innovation April 16, 2023
What is the financial cost of preventable needlestick injuries?
Needlestick injuries (NSIs) pose a significant clinical and economic threat to healthcare institutions globally. When most are considered largely preventable,…
Events and training April 9, 2023
Development of a vascular access team: One size does not fit all
The benefits of a vascular access team are no secret. NIVAS (The UK National Infusion and Vascular Access Society) claims…
News and innovation April 2, 2023
Nordics and the U.K. set standards for sustainable procurement
To fight against climate change, Norwegian health authorities have committed to a 40% reduction in CO2 emissions by 2030 and…
News and innovation March 26, 2023
New Spanish vascular access team standard
On 4th November 2022, the Spanish Society of Infusion and Vascular Access (SEINAV: Sociedad Española de Infusión y Acceso Vascular)…
Fast fact
TIVA anaesthesia
Propofol-based total intravenous anaesthesia (TIVA) emits four orders of magnitude less greenhouse gases than inhaled anaesthesia with desflurane and N2O.